← All companies
FBIO
Fortress Biotech, Inc.
$2.76
-0.53 -16.11%
Key statistics
from XBRL data in SEC filingsMarket cap
$106M
Revenue (TTM)
$66.2M
Net income (TTM)
$158M
EPS (TTM)
$3.23
P/E ratio
0.9
Dividend yield
—
Free cash flow
—
Cash
$256M
Total assets
$357M
Gross margin
—
52-week range
$1.79 – $4.53
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Shareholder vote results
Jun 23, 2026
10-Q
Quarter ended 2026-03-31
May 14, 2026
8-K
Results of operations (earnings release)
May 14, 2026
10-K
Fiscal year ended 2025-12-31
Mar 31, 2026
8-K
Results of operations (earnings release)
Mar 31, 2026
8-K
Other events
Mar 30, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Other events
Feb 23, 2026
8-K
Other events
Jan 13, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Dec 15, 2025
8-K
Other events
Dec 15, 2025
8-K
Other events
Nov 17, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Results of operations (earnings release)
Nov 14, 2025
8-K
Other events
Oct 1, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Results of operations (earnings release)
Aug 14, 2025
8-K
Other events
Jul 16, 2025
8-K
Shareholder vote results
Jun 23, 2025
8-K
Completed an acquisition or disposition
Jun 5, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
8-K
Results of operations (earnings release)
May 15, 2025
8-K
Director or officer change
Apr 16, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Results of operations (earnings release)
Mar 31, 2025
8-K
Entered a material agreement
Mar 10, 2025
8-K
Other events
Jan 16, 2025
8-K
Other events
Jan 6, 2025
8-K
Other events
Dec 16, 2024
10-Q
Quarter ended 2024-09-30
Nov 14, 2024
8-K
Results of operations (earnings release)
Nov 14, 2024
8-K
Other events
Nov 4, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Sep 23, 2024
10-Q
Quarter ended 2024-06-30
Aug 13, 2024
8-K
Results of operations (earnings release)
Aug 13, 2024
8-K
Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Jul 25, 2024
8-K
Entered a material agreement
Jul 19, 2024
8-K
Other events
Jul 5, 2024
8-K
Unregistered sale of equity
Jun 28, 2024
8-K
Amended charter or bylaws
Jun 25, 2024
8-K
Director or officer change; Shareholder vote results
May 29, 2024